首页 | 本学科首页   官方微博 | 高级检索  
检索        

温郁金抗新型冠状病毒肺炎(COVID-19)的机制探索
引用本文:秦宇雯,赵祺,赵宇烁,任仙樱,鲍康德,李校堃,姜程曦.温郁金抗新型冠状病毒肺炎(COVID-19)的机制探索[J].中草药,2020,51(8):1977-1983.
作者姓名:秦宇雯  赵祺  赵宇烁  任仙樱  鲍康德  李校堃  姜程曦
作者单位:温州大学生命科学研究院, 浙江 温州 325035;温州医科大学药学院, 浙江 温州 325035;浙江省生物医药协同创新中心, 浙江 温州 325035;温州医科大学药学院, 浙江 温州 325035;合肥市未来药物开发有限公司, 安徽 合肥 230000;温州大学生命科学研究院, 浙江 温州 325035;浙江省生物医药协同创新中心, 浙江 温州 325035;温州大学生命科学研究院, 浙江 温州 325035;合肥市未来药物开发有限公司, 安徽 合肥 230000
基金项目:浙江大学新型冠状病毒肺炎(COVID-19)应急科研专项(2020XGZX029);温州市新型冠状病毒肺炎疫情防控应急攻关项目(ZY202002);合肥市未来药物开发有限公司-浙大应急科研专项横向课题(2020XGZX029);云南大理药业股份有限公司横向课题(KJHX1603)
摘    要:新型冠状病毒肺炎(COVID-19)具有流行性广、传染性强、发病急骤和病情危重等特点,目前对于COVID-19主要采用中西医结合治疗方法,临床效果显著,凸显中医药在抗病毒方面的优势。早期大量药理药效学和临床研究证实温郁金具有显著抗病毒作用,对病毒性肺炎、上呼吸道感染等呼吸系统疾病疗效确切。此外,温郁金还具有一定抗肺纤维化作用,提示其可能会对由COVID-19引发的肺损伤有缓解或治疗作用。通过对温郁金抗病毒的化学成分、药理作用、机制研究和临床应用进行总结梳理,并从中医角度分析COVID-19的病因机制和辨证治法,以期为温郁金临床治疗COVID-19和后续相关药物研发提供参考。

关 键 词:温郁金  严重急性呼吸综合征冠状病毒2  新型冠状病毒肺炎  抗病毒  病毒性肺炎  抗肺纤维化
收稿时间:2020/3/2 0:00:00

Exploring mechanism of Curcuma wenyujin against COVID-19
QIN Yu-wen,ZHAO Qi,ZHAO Yu-shuo,REN Xian-ying,BAO Kang-de,LI Xiao-kun,JIANG Cheng-xi.Exploring mechanism of Curcuma wenyujin against COVID-19[J].Chinese Traditional and Herbal Drugs,2020,51(8):1977-1983.
Authors:QIN Yu-wen  ZHAO Qi  ZHAO Yu-shuo  REN Xian-ying  BAO Kang-de  LI Xiao-kun  JIANG Cheng-xi
Institution:Institute of Life Sciences, Wenzhou University, Wenzhou 325035, China;College of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China;Zhejiang Collaborative Innovation Center of Biomedicines, Wenzhou 325035, China;College of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China;Hefei Future Drug Development Co., Ltd., Hefei 230000, China;Institute of Life Sciences, Wenzhou University, Wenzhou 325035, China;Zhejiang Collaborative Innovation Center of Biomedicines, Wenzhou 325035, China; Institute of Life Sciences, Wenzhou University, Wenzhou 325035, China;Hefei Future Drug Development Co., Ltd., Hefei 230000, China
Abstract:Coronavirus disease 2019 (COVID-19) has the characteristics of widespread epidemic, strong infectivity, rapid onset and critical illness. At present, many hospitals adopt integrated Chinese and Western medicine treatment methods, which have significant clinical effects, highlighting the antiviral effect of traditional Chinese medicine in. A large number of early pharmacological and pharmacodynamic and clinical research results have confirmed that medicinal plants Curcuma wenyujin has a significant antiviral effect, and it is effective for respiratory diseases such as viral pneumonia and upper respiratory tract infection. In addition, medicinal plants C. wenyujin also has a certain anti-pulmonary fibrosis effect, suggesting that it may alleviate or treat lung injury caused by COVID-19. Through summarizing and combing the chemical composition, pharmacological action, mechanism research and clinical application of antiviral of medicinal plants C. wenyujin, and analyzing the etiology mechanism and dialectical treatment of COVID-19 from the perspective of traditional Chinese medicine, with a view to providing a reference for the clinical treatment of COVID-19 infection and subsequent related drug development.
Keywords:Curcuma wenyujin Y  H  Chen et C  Ling  SARS-CoV-2  COVID-19  antiviral  viral pneumonia  anti-pulmonary fibrosis
本文献已被 CNKI 等数据库收录!
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号